Baird, an employee-owned, international financial services firm, today announced that it has added Robert (“Rob”) J. Andrews Jr., to the firm’s Healthcare Investment Banking team as a Managing Director. Andrews will focus primarily on healthcare product and device related sectors and will also assist with Baird’s coverage of healthcare services and life sciences. With more than 20 years of banking experience, Andrews’ addition continues the rapid expansion of Baird’s Healthcare banking effort. He will be based in Baird’s Chicago office.
Andrews was formerly with CIT Group where he was a Managing Director and led the firm’s investment banking and lending activities in the medical device sector. Prior to CIT, Andrews held investment banking positions at Stout Risius Ross Advisors, Houlihan Lokey, Lazard and ABN AMRO. He has a bachelor’s degree from Boston College and a M.B.A. from the University of Chicago Booth School of Business.
“We are very pleased that Rob has decided to join Baird’s Healthcare team,” said Steve Booth, Baird’s Chief Operating Officer and Director of Investment Banking. “He adds strong sector relationships and deep industry expertise to our healthcare franchise, which will help Baird best serve its clients.”
Brian Doyal, Head of Baird’s Healthcare Investment Banking team, added: “Rob will be a great addition to our Healthcare banking effort. He embraces Baird’s teamwork-oriented and clients-come-first culture, and we are excited about teaming Rob up with members of our existing healthcare group to expand and deepen our health care relationships.”
Recent notable deals for Baird's Healthcare Investment Banking team include:
- $65 million initial public offering for Ambit Biosciences Corporation
- Joint Bookrunner for Exact Sciences Corporation’s $78 million follow-on offering
- Sale of Unisyn Medical Technologies’ Transactional Business to GE Healthcare for undisclosed amount
- $1.1 billion initial public offering for Quintiles Transnational Holdings, Inc.
- Sale of CoreLab Partners, Inc. to JLL Partners, Inc. for undisclosed amount
- Sale of Young Innovations, Inc. to Linden Capital Partners for $297 Million
- Acquisition of Precision Dynamics Corporation by Brady Corporation for $300 million
About Baird Investment Banking
Recognized as the 2011 “Investment Banking Firm of the Year” by The M&A Advisor, Baird is a leading global investment bank focused on the middle market. Approximately 250 investment banking professionals in the U.S., Europe and Asia provide corporations, private equity and venture capital firms with in-depth market knowledge and extensive experience in merger and acquisition and equity financing transactions. Since 2008, Baird has advised on nearly 250 M&A transactions representing approximately $50 billion in transaction value and has served as lead or co-manager on 335 equity offerings raising approximately $98 billion. Baird has received “Deal of the Year” recognitions from The M&A Advisor for eight years running, demonstrating commitment to attaining great outcomes for clients.
Baird is an employee-owned, international wealth management, capital markets, private equity and asset management firm with offices in the United States, Europe and Asia. Established in 1919, Baird has approximately 2,800 associates serving the needs of individual, corporate, institutional and municipal clients. Baird had $105 billion in client assets as of June 30, 2013. Committed to being a great place to work, Baird ranked No. 14 on FORTUNE’s 100 Best Companies to Work For in 2013 – its tenth consecutive year on the list. Baird’s principal operating subsidiaries are Robert W. Baird & Co. in the United States and Robert W. Baird Group Ltd. in Europe. Baird also has an operating subsidiary in Asia supporting Baird’s investment banking and private equity operations. For more information, please visit Baird’s Web site at www.rwbaird.com and www.bairdeurope.com.
Baird Public Relations